Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Steven Durrington who wrote (2316)	4/4/1998 8:19:00 AM
From: ENOTS	Read Replies (1) \| Respond to of 3725

Thanks, I read about this in the Johns Hopkins Intelihealth email and was just curious! Thank you!

To: Steven Durrington who wrote (2316)	4/4/1998 8:55:00 AM
From: art slott	Respond to of 3725

(OFF TOPIC} Hello Steve from Saudi Arabia. Was that by choice? How goes it with Gift? I had followed it for a while. Any big court case imminent? ART

To: Steven Durrington who wrote (2316)	4/4/1998 11:36:00 AM
From: Brian Moloney	Respond to of 3725

That is an excellent explanation. There is a new test in our community which is a blood test that is a marker for a heart attack. It is supposed to be better than the traditional blood test (CPK), but the pertinent piece of info for all Imatron owners is that these tests are for detection of myocardial infarctions. This does not cut into the Imatron market which is to screen for coronary disease that would show up long before a treadmill or even a nuclear scan would show disease.